Latest filings (excl ownership)
DEFA14A
Additional proxy soliciting materials
29 Apr 24
DEF 14A
Definitive proxy
29 Apr 24
10-K/A
2023 FY
Annual report (amended)
23 Apr 24
S-8
Registration of securities for employees
22 Feb 24
10-K
2023 FY
Annual report
22 Feb 24
8-K
Health Catalyst Reports Fourth Quarter and Year End 2023 Results
22 Feb 24
8-K
Other Events
8 Jan 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
8-K
Health Catalyst Reports Third Quarter 2023 Results
2 Nov 23
8-K
Health Catalyst Reports Third Quarter 2023 Preliminary Results
27 Oct 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
8-K
Health Catalyst Reports Second Quarter 2023 Results
8 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 23
10-Q
2023 Q1
Quarterly report
9 May 23
8-K
Health Catalyst Reports First Quarter 2023 Results
9 May 23
DEFA14A
Additional proxy soliciting materials
27 Apr 23
DEF 14A
Definitive proxy
27 Apr 23
8-K
Departure of Directors or Certain Officers
30 Mar 23
8-K
Regulation FD Disclosure
10 Mar 23
S-8
Registration of securities for employees
28 Feb 23
8-K
Departure of Directors or Certain Officers
28 Feb 23
10-K
2022 FY
Annual report
28 Feb 23
8-K
Health Catalyst Reports Fourth Quarter and Year End 2022 Results
28 Feb 23
8-K
Overview Presentation January 2023
9 Jan 23
8-K
Health Catalyst Announces New, External Leadership Assignment for Paul Horstmeier
6 Jan 23
8-K/A
Departure of Directors or Certain Officers
6 Jan 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
8-K
Health Catalyst Reports Third Quarter 2022 Results
8 Nov 22
8-K
Health Catalyst Announces New Leadership Assignments in Support of Strategic Focus Areas
7 Sep 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
8-K
Health Catalyst Announces $40 Million Share Repurchase Program
4 Aug 22
8-K
Health Catalyst Reports Second Quarter 2022 Results
4 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
17 Jun 22
D
$6M in equity, sold $6M, 3 investors
12 May 22
8-K
Health Catalyst Reports First Quarter 2022 Results
10 May 22
10-Q
2022 Q1
Quarterly report
10 May 22
DEFA14A
Additional proxy soliciting materials
27 Apr 22
DEF 14A
Definitive proxy
27 Apr 22
D
$13.49M in equity, sold $13.49M, 16 investors
2 Mar 22
S-8
Registration of securities for employees
1 Mar 22
Latest ownership filings
4
Linda Llewelyn
17 Apr 24
144
Notice of proposed sale of securities
15 Apr 24
4
Linda Llewelyn
19 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
4
Daniel LeSueur
5 Mar 24
4
Jason Alger
5 Mar 24
4
Benjamin Landry
5 Mar 24
4
Bryan Truman Hunt
5 Mar 24
4
Kevin Lee Freeman
5 Mar 24
4
Daniel D. Burton
5 Mar 24
4
Linda Llewelyn
5 Mar 24
3
Daniel LeSueur
5 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
4
Daniel D. Burton
27 Feb 24
4
Daniel D. Burton
22 Feb 24
4
Kevin Lee Freeman
22 Feb 24
4
Benjamin Landry
22 Feb 24
4
Linda Llewelyn
22 Feb 24
4
Jason Alger
22 Feb 24
4
Bryan Truman Hunt
22 Feb 24
4
Linda Llewelyn
20 Feb 24
144
Notice of proposed sale of securities
15 Feb 24
SC 13G/A
Point72 Asset Management, L.P.
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G
WELLINGTON MANAGEMENT GROUP LLP
8 Feb 24
SC 13G/A
BlackRock Inc.
24 Jan 24
4
Linda Llewelyn
18 Jan 24
144
Notice of proposed sale of securities
16 Jan 24
4
Linda Llewelyn
19 Dec 23
144
Notice of proposed sale of securities
15 Dec 23
4
Jason Alger
7 Dec 23
144
Notice of proposed sale of securities
6 Dec 23
4
Anne Marie Bickmore
5 Dec 23